on 24 Jan 2025
Last Applicant/ Owned by
Novartis AG
CH-4002 Basel
CH
Serial Number
2302191 filed on 8th Nov 2023
Registration Number
TMA1286975 registered on 24th Jan 2025
Registration expiry Date
8th Nov 2033Trademark usage description
préparations pharmaceutiques pour la prévention et le traitement des maladies immunologiques, à savoir des maladies auto-immunes, des syndromes de déf Read More12
2302191
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 42 on 6th Nov 2024 | Advertised |
Submitted for opposition 256 on 28th Oct 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 26 on 30th Sept 2024 | Approved |
Submitted for opposition 27 on 30th Sept 2024 | Approval Notice Sent |
Submitted for opposition 22 on 20th Sept 2024 | Search Recorded |
Submitted for opposition 257 on 28th Dec 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 27th Dec 2023 | Formalized |
Submitted for opposition 1 on 27th Dec 2023 | Created |
Submitted for opposition 228 on 8th Nov 2023 | International Registration |
Submitted for opposition 30 on 8th Nov 2023 | Filed |